The analyst points to 908 Devices for its innovation in miniaturizing mass spectrometry, a key method for studying proteins. This advancement is critical for making proteomics more accessible and efficient, a field that is currently underfunded but holds immense potential for biological understanding and therapeutic development.
“then we have companies such 908 which basically manag to miniaturize mass spec which is one of the main methods to actually study the proteins”